aluates Reports

$ 0.0

Automative

Global Healthcare-Acquired Infection Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-24Z5686

Global and United States Healthcare Acquired Infection Market Report Forecast 2022 2028

BUY CHAPTERS

Global Healthcare-Acquired Infection Market Insights, Forecast to 2030

Code: QYRE-Auto-24Z5686

Report

December 2024

Pages:91

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

Novartis

Roche

Sanofi

Abbott

Hologic Inc

Healthcare-Acquired Infection Market Size

The global Healthcare-Acquired Infection market is projected to grow from US$ 26230 million in 2024 to US$ 40550 million by 2030, at a Compound Annual Growth Rate (CAGR) of 7.5% during the forecast period.

Healthcare-Acquired Infection Market

The healthcare-acquired infection is a new infection that develops in a patient during hospitalization.

Market Analysis and Insights: Global Healthcare-Acquired Infection Market

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Covers:

This report presents an overview of global market for Healthcare-Acquired Infection market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Healthcare-Acquired Infection, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Healthcare-Acquired Infection, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Healthcare-Acquired Infection revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Healthcare-Acquired Infection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Healthcare-Acquired Infection revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Healthcare-Acquired Infection Market Report

Report Metric	Details
Report Name	Healthcare-Acquired Infection Market
Accounted market size in 2024	US$ 26230 in million
Forecasted market size in 2030	US$ 40550 million
CAGR	7.5
Base Year	2024
Forecasted years	2025 - 2030
Segment by Type	Pharmaceutical Treatment Environment Treatment Medical Devices Management
Segment by Application	Hospital Clinics Ambulatory Surgery Centers Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Novartis, Roche, Sanofi, Abbott, BD, Hologic
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Healthcare-Acquired Infection in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Healthcare-Acquired Infection companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Healthcare-Acquired Infection revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Healthcare-Acquired Infection Market growing?

Ans: The Healthcare-Acquired Infection Market witnessing a CAGR of 7.5 during the forecast period 2025-2030.

What is the Healthcare-Acquired Infection Market size in 2030?

Ans: The Healthcare-Acquired Infection Market size in 2030 will be US$ 40550 million.

Who are the main players in the Healthcare-Acquired Infection Market report?

Ans: The main players in the Healthcare-Acquired Infection Market are Pfizer, Novartis, Roche, Sanofi, Abbott, BD, Hologic

What are the Application segmentation covered in the Healthcare-Acquired Infection Market report?

Ans: The Applications covered in the Healthcare-Acquired Infection Market report are Hospital, Clinics, Ambulatory Surgery Centers, Others

What are the Type segmentation covered in the Healthcare-Acquired Infection Market report?

Ans: The Types covered in the Healthcare-Acquired Infection Market report are Pharmaceutical Treatment, Environment Treatment, Medical Devices Management

Recommended Reports

Hospital Infrastructure

Medical Devices & Equipment

Critical Care & ICU

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Healthcare-Acquired Infection Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Pharmaceutical Treatment

1.2.3 Environment Treatment

1.2.4 Medical Devices Management

1.3 Market by Application

1.3.1 Global Healthcare-Acquired Infection Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Clinics

1.3.4 Ambulatory Surgery Centers

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Healthcare-Acquired Infection Market Perspective (2019-2030)

2.2 Global Healthcare-Acquired Infection Growth Trends by Region

2.2.1 Healthcare-Acquired Infection Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Healthcare-Acquired Infection Historic Market Size by Region (2019-2024)

2.2.3 Healthcare-Acquired Infection Forecasted Market Size by Region (2025-2030)

2.3 Healthcare-Acquired Infection Market Dynamics

2.3.1 Healthcare-Acquired Infection Industry Trends

2.3.2 Healthcare-Acquired Infection Market Drivers

2.3.3 Healthcare-Acquired Infection Market Challenges

2.3.4 Healthcare-Acquired Infection Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Healthcare-Acquired Infection by Players

3.1.1 Global Healthcare-Acquired Infection Revenue by Players (2019-2024)

3.1.2 Global Healthcare-Acquired Infection Revenue Market Share by Players (2019-2024)

3.2 Global Healthcare-Acquired Infection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Healthcare-Acquired Infection, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Healthcare-Acquired Infection Market Concentration Ratio

3.4.1 Global Healthcare-Acquired Infection Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Healthcare-Acquired Infection Revenue in 2023

3.5 Global Key Players of Healthcare-Acquired Infection Head office and Area Served

3.6 Global Key Players of Healthcare-Acquired Infection, Product and Application

3.7 Global Key Players of Healthcare-Acquired Infection, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Healthcare-Acquired Infection Breakdown Data by Type

4.1 Global Healthcare-Acquired Infection Historic Market Size by Type (2019-2024)

4.2 Global Healthcare-Acquired Infection Forecasted Market Size by Type (2025-2030)

5 Healthcare-Acquired Infection Breakdown Data by Application

5.1 Global Healthcare-Acquired Infection Historic Market Size by Application (2019-2024)

5.2 Global Healthcare-Acquired Infection Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Healthcare-Acquired Infection Market Size (2019-2030)

6.2 North America Healthcare-Acquired Infection Market Size by Type

6.2.1 North America Healthcare-Acquired Infection Market Size by Type (2019-2024)

6.2.2 North America Healthcare-Acquired Infection Market Size by Type (2025-2030)

6.2.3 North America Healthcare-Acquired Infection Market Share by Type (2019-2030)

6.3 North America Healthcare-Acquired Infection Market Size by Application

6.3.1 North America Healthcare-Acquired Infection Market Size by Application (2019-2024)

6.3.2 North America Healthcare-Acquired Infection Market Size by Application (2025-2030)

6.3.3 North America Healthcare-Acquired Infection Market Share by Application (2019-2030)

6.4 North America Healthcare-Acquired Infection Market Size by Country

6.4.1 North America Healthcare-Acquired Infection Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Healthcare-Acquired Infection Market Size by Country (2019-2024)

6.4.3 North America Healthcare-Acquired Infection Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Healthcare-Acquired Infection Market Size (2019-2030)

7.2 Europe Healthcare-Acquired Infection Market Size by Type

7.2.1 Europe Healthcare-Acquired Infection Market Size by Type (2019-2024)

7.2.2 Europe Healthcare-Acquired Infection Market Size by Type (2025-2030)

7.2.3 Europe Healthcare-Acquired Infection Market Share by Type (2019-2030)

7.3 Europe Healthcare-Acquired Infection Market Size by Application

7.3.1 Europe Healthcare-Acquired Infection Market Size by Application (2019-2024)

7.3.2 Europe Healthcare-Acquired Infection Market Size by Application (2025-2030)

7.3.3 Europe Healthcare-Acquired Infection Market Share by Application (2019-2030)

7.4 Europe Healthcare-Acquired Infection Market Size by Country

7.4.1 Europe Healthcare-Acquired Infection Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Healthcare-Acquired Infection Market Size by Country (2019-2024)

7.4.3 Europe Healthcare-Acquired Infection Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Healthcare-Acquired Infection Market Size (2019-2030)

8.2 China Healthcare-Acquired Infection Market Size by Type

8.2.1 China Healthcare-Acquired Infection Market Size by Type (2019-2024)

8.2.2 China Healthcare-Acquired Infection Market Size by Type (2025-2030)

8.2.3 China Healthcare-Acquired Infection Market Share by Type (2019-2030)

8.3 China Healthcare-Acquired Infection Market Size by Application

8.3.1 China Healthcare-Acquired Infection Market Size by Application (2019-2024)

8.3.2 China Healthcare-Acquired Infection Market Size by Application (2025-2030)

8.3.3 China Healthcare-Acquired Infection Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Healthcare-Acquired Infection Market Size (2019-2030)

9.2 Asia Healthcare-Acquired Infection Market Size by Type

9.2.1 Asia Healthcare-Acquired Infection Market Size by Type (2019-2024)

9.2.2 Asia Healthcare-Acquired Infection Market Size by Type (2025-2030)

9.2.3 Asia Healthcare-Acquired Infection Market Share by Type (2019-2030)

9.3 Asia Healthcare-Acquired Infection Market Size by Application

9.3.1 Asia Healthcare-Acquired Infection Market Size by Application (2019-2024)

9.3.2 Asia Healthcare-Acquired Infection Market Size by Application (2025-2030)

9.3.3 Asia Healthcare-Acquired Infection Market Share by Application (2019-2030)

9.4 Asia Healthcare-Acquired Infection Market Size by Region

9.4.1 Asia Healthcare-Acquired Infection Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Healthcare-Acquired Infection Market Size by Region (2019-2024)

9.4.3 Asia Healthcare-Acquired Infection Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Healthcare-Acquired Infection Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Healthcare-Acquired Infection Market Size by Type

10.2.1 Middle East, Africa, and Latin America Healthcare-Acquired Infection Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Healthcare-Acquired Infection Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Healthcare-Acquired Infection Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Healthcare-Acquired Infection Market Size by Application

10.3.1 Middle East, Africa, and Latin America Healthcare-Acquired Infection Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Healthcare-Acquired Infection Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Healthcare-Acquired Infection Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Healthcare-Acquired Infection Market Size by Country

10.4.1 Middle East, Africa, and Latin America Healthcare-Acquired Infection Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Healthcare-Acquired Infection Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Healthcare-Acquired Infection Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Healthcare-Acquired Infection Introduction

11.1.4 Pfizer Revenue in Healthcare-Acquired Infection Business (2019-2024)

11.1.5 Pfizer Recent Developments

11.2 Novartis

11.2.1 Novartis Company Details

11.2.2 Novartis Business Overview

11.2.3 Novartis Healthcare-Acquired Infection Introduction

11.2.4 Novartis Revenue in Healthcare-Acquired Infection Business (2019-2024)

11.2.5 Novartis Recent Developments

11.3 Roche

11.3.1 Roche Company Details

11.3.2 Roche Business Overview

11.3.3 Roche Healthcare-Acquired Infection Introduction

11.3.4 Roche Revenue in Healthcare-Acquired Infection Business (2019-2024)

11.3.5 Roche Recent Developments

11.4 Sanofi

11.4.1 Sanofi Company Details

11.4.2 Sanofi Business Overview

11.4.3 Sanofi Healthcare-Acquired Infection Introduction

11.4.4 Sanofi Revenue in Healthcare-Acquired Infection Business (2019-2024)

11.4.5 Sanofi Recent Developments

11.5 Abbott

11.5.1 Abbott Company Details

11.5.2 Abbott Business Overview

11.5.3 Abbott Healthcare-Acquired Infection Introduction

11.5.4 Abbott Revenue in Healthcare-Acquired Infection Business (2019-2024)

11.5.5 Abbott Recent Developments

11.6 BD

11.6.1 BD Company Details

11.6.2 BD Business Overview

11.6.3 BD Healthcare-Acquired Infection Introduction

11.6.4 BD Revenue in Healthcare-Acquired Infection Business (2019-2024)

11.6.5 BD Recent Developments

11.7 Hologic

11.7.1 Hologic Company Details

11.7.2 Hologic Business Overview

11.7.3 Hologic Healthcare-Acquired Infection Introduction

11.7.4 Hologic Revenue in Healthcare-Acquired Infection Business (2019-2024)

11.7.5 Hologic Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Pfizer Inc

Novartis

Roche

Sanofi

Abbott

Hologic Inc

List of Tables

Table 1. Global Healthcare-Acquired Infection Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Pharmaceutical Treatment

Table 3. Key Players of Environment Treatment

Table 4. Key Players of Medical Devices Management

Table 5. Global Healthcare-Acquired Infection Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 6. Global Healthcare-Acquired Infection Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Healthcare-Acquired Infection Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Healthcare-Acquired Infection Market Share by Region (2019-2024)

Table 9. Global Healthcare-Acquired Infection Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Healthcare-Acquired Infection Market Share by Region (2025-2030)

Table 11. Healthcare-Acquired Infection Market Trends

Table 12. Healthcare-Acquired Infection Market Drivers

Table 13. Healthcare-Acquired Infection Market Challenges

Table 14. Healthcare-Acquired Infection Market Restraints

Table 15. Global Healthcare-Acquired Infection Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Healthcare-Acquired Infection Revenue Share by Players (2019-2024)

Table 17. Global Top Healthcare-Acquired Infection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Healthcare-Acquired Infection as of 2023)

Table 18. Global Healthcare-Acquired Infection Industry Ranking 2022 VS 2023 VS 2024

Table 19. Global 5 Largest Players Market Share by Healthcare-Acquired Infection Revenue (CR5 and HHI) & (2019-2024)

Table 20. Global Key Players of Healthcare-Acquired Infection, Headquarters and Area Served

Table 21. Global Key Players of Healthcare-Acquired Infection, Product and Application

Table 22. Global Key Players of Healthcare-Acquired Infection, Product and Application

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Healthcare-Acquired Infection Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Healthcare-Acquired Infection Revenue Market Share by Type (2019-2024)

Table 26. Global Healthcare-Acquired Infection Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Healthcare-Acquired Infection Revenue Market Share by Type (2025-2030)

Table 28. Global Healthcare-Acquired Infection Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Healthcare-Acquired Infection Revenue Share by Application (2019-2024)

Table 30. Global Healthcare-Acquired Infection Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Healthcare-Acquired Infection Revenue Share by Application (2025-2030)

Table 32. North America Healthcare-Acquired Infection Market Size by Type (2019-2024) & (US$ Million)

Table 33. North America Healthcare-Acquired Infection Market Size by Type (2025-2030) & (US$ Million)

Table 34. North America Healthcare-Acquired Infection Market Size by Application (2019-2024) & (US$ Million)

Table 35. North America Healthcare-Acquired Infection Market Size by Application (2025-2030) & (US$ Million)

Table 36. North America Healthcare-Acquired Infection Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. North America Healthcare-Acquired Infection Market Size by Country (2019-2024) & (US$ Million)

Table 38. North America Healthcare-Acquired Infection Market Size by Country (2025-2030) & (US$ Million)

Table 39. Europe Healthcare-Acquired Infection Market Size by Type (2019-2024) & (US$ Million)

Table 40. Europe Healthcare-Acquired Infection Market Size by Type (2025-2030) & (US$ Million)

Table 41. Europe Healthcare-Acquired Infection Market Size by Application (2019-2024) & (US$ Million)

Table 42. Europe Healthcare-Acquired Infection Market Size by Application (2025-2030) & (US$ Million)

Table 43. Europe Healthcare-Acquired Infection Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Europe Healthcare-Acquired Infection Market Size by Country (2019-2024) & (US$ Million)

Table 45. Europe Healthcare-Acquired Infection Market Size by Country (2025-2030) & (US$ Million)

Table 46. China Healthcare-Acquired Infection Market Size by Type (2019-2024) & (US$ Million)

Table 47. China Healthcare-Acquired Infection Market Size by Type (2025-2030) & (US$ Million)

Table 48. China Healthcare-Acquired Infection Market Size by Application (2019-2024) & (US$ Million)

Table 49. China Healthcare-Acquired Infection Market Size by Application (2025-2030) & (US$ Million)

Table 50. Asia Healthcare-Acquired Infection Market Size by Type (2019-2024) & (US$ Million)

Table 51. Asia Healthcare-Acquired Infection Market Size by Type (2025-2030) & (US$ Million)

Table 52. Asia Healthcare-Acquired Infection Market Size by Application (2019-2024) & (US$ Million)

Table 53. Asia Healthcare-Acquired Infection Market Size by Application (2025-2030) & (US$ Million)

Table 54. Asia Healthcare-Acquired Infection Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 55. Asia Healthcare-Acquired Infection Market Size by Region (2019-2024) & (US$ Million)

Table 56. Asia Healthcare-Acquired Infection Market Size by Region (2025-2030) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Healthcare-Acquired Infection Market Size by Type (2019-2024) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Healthcare-Acquired Infection Market Size by Type (2025-2030) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Healthcare-Acquired Infection Market Size by Application (2019-2024) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Healthcare-Acquired Infection Market Size by Application (2025-2030) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Healthcare-Acquired Infection Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 62. Middle East, Africa, and Latin America Healthcare-Acquired Infection Market Size by Country (2019-2024) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Healthcare-Acquired Infection Market Size by Country (2025-2030) & (US$ Million)

Table 64. Pfizer Company Details

Table 65. Pfizer Business Overview

Table 66. Pfizer Healthcare-Acquired Infection Product

Table 67. Pfizer Revenue in Healthcare-Acquired Infection Business (2019-2024) & (US$ Million)

Table 68. Pfizer Recent Developments

Table 69. Novartis Company Details

Table 70. Novartis Business Overview

Table 71. Novartis Healthcare-Acquired Infection Product

Table 72. Novartis Revenue in Healthcare-Acquired Infection Business (2019-2024) & (US$ Million)

Table 73. Novartis Recent Developments

Table 74. Roche Company Details

Table 75. Roche Business Overview

Table 76. Roche Healthcare-Acquired Infection Product

Table 77. Roche Revenue in Healthcare-Acquired Infection Business (2019-2024) & (US$ Million)

Table 78. Roche Recent Developments

Table 79. Sanofi Company Details

Table 80. Sanofi Business Overview

Table 81. Sanofi Healthcare-Acquired Infection Product

Table 82. Sanofi Revenue in Healthcare-Acquired Infection Business (2019-2024) & (US$ Million)

Table 83. Sanofi Recent Developments

Table 84. Abbott Company Details

Table 85. Abbott Business Overview

Table 86. Abbott Healthcare-Acquired Infection Product

Table 87. Abbott Revenue in Healthcare-Acquired Infection Business (2019-2024) & (US$ Million)

Table 88. Abbott Recent Developments

Table 89. BD Company Details

Table 90. BD Business Overview

Table 91. BD Healthcare-Acquired Infection Product

Table 92. BD Revenue in Healthcare-Acquired Infection Business (2019-2024) & (US$ Million)

Table 93. BD Recent Developments

Table 94. Hologic Company Details

Table 95. Hologic Business Overview

Table 96. Hologic Healthcare-Acquired Infection Product

Table 97. Hologic Revenue in Healthcare-Acquired Infection Business (2019-2024) & (US$ Million)

Table 98. Hologic Recent Developments

Table 99. Research Programs/Design for This Report

Table 100. Key Data Information from Secondary Sources

Table 101. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Healthcare-Acquired Infection Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Healthcare-Acquired Infection Market Share by Type: 2023 VS 2030

Figure 3. Pharmaceutical Treatment Features

Figure 4. Environment Treatment Features

Figure 5. Medical Devices Management Features

Figure 6. Global Healthcare-Acquired Infection Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Healthcare-Acquired Infection Market Share by Application: 2023 VS 2030

Figure 8. Hospital Case Studies

Figure 9. Clinics Case Studies

Figure 10. Ambulatory Surgery Centers Case Studies

Figure 11. Others Case Studies

Figure 12. Healthcare-Acquired Infection Report Years Considered

Figure 13. Global Healthcare-Acquired Infection Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Healthcare-Acquired Infection Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Healthcare-Acquired Infection Market Share by Region: 2023 VS 2030

Figure 16. Global Healthcare-Acquired Infection Market Share by Players in 2023

Figure 17. Global Top Healthcare-Acquired Infection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Healthcare-Acquired Infection as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Healthcare-Acquired Infection Revenue in 2023

Figure 19. North America Healthcare-Acquired Infection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Healthcare-Acquired Infection Market Share by Type (2019-2030)

Figure 21. North America Healthcare-Acquired Infection Market Share by Application (2019-2030)

Figure 22. North America Healthcare-Acquired Infection Market Share by Country (2019-2030)

Figure 23. United States Healthcare-Acquired Infection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Healthcare-Acquired Infection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Healthcare-Acquired Infection Market Size YoY (2019-2030) & (US$ Million)

Figure 26. Europe Healthcare-Acquired Infection Market Share by Type (2019-2030)

Figure 27. Europe Healthcare-Acquired Infection Market Share by Application (2019-2030)

Figure 28. Europe Healthcare-Acquired Infection Market Share by Country (2019-2030)

Figure 29. Germany Healthcare-Acquired Infection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. France Healthcare-Acquired Infection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. U.K. Healthcare-Acquired Infection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Italy Healthcare-Acquired Infection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Russia Healthcare-Acquired Infection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Nordic Countries Healthcare-Acquired Infection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. China Healthcare-Acquired Infection Market Size YoY (2019-2030) & (US$ Million)

Figure 36. China Healthcare-Acquired Infection Market Share by Type (2019-2030)

Figure 37. China Healthcare-Acquired Infection Market Share by Application (2019-2030)

Figure 38. Asia Healthcare-Acquired Infection Market Size YoY (2019-2030) & (US$ Million)

Figure 39. Asia Healthcare-Acquired Infection Market Share by Type (2019-2030)

Figure 40. Asia Healthcare-Acquired Infection Market Share by Application (2019-2030)

Figure 41. Asia Healthcare-Acquired Infection Market Share by Region (2019-2030)

Figure 42. Japan Healthcare-Acquired Infection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. South Korea Healthcare-Acquired Infection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. China Taiwan Healthcare-Acquired Infection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Southeast Asia Healthcare-Acquired Infection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. India Healthcare-Acquired Infection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Australia Healthcare-Acquired Infection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Healthcare-Acquired Infection Market Size YoY (2019-2030) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Healthcare-Acquired Infection Market Share by Type (2019-2030)

Figure 50. Middle East, Africa, and Latin America Healthcare-Acquired Infection Market Share by Application (2019-2030)

Figure 51. Middle East, Africa, and Latin America Healthcare-Acquired Infection Market Share by Country (2019-2030)

Figure 52. Brazil Healthcare-Acquired Infection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Mexico Healthcare-Acquired Infection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Turkey Healthcare-Acquired Infection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Saudi Arabia Healthcare-Acquired Infection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Israel Healthcare-Acquired Infection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. GCC Countries Healthcare-Acquired Infection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. Pfizer Revenue Growth Rate in Healthcare-Acquired Infection Business (2019-2024)

Figure 59. Novartis Revenue Growth Rate in Healthcare-Acquired Infection Business (2019-2024)

Figure 60. Roche Revenue Growth Rate in Healthcare-Acquired Infection Business (2019-2024)

Figure 61. Sanofi Revenue Growth Rate in Healthcare-Acquired Infection Business (2019-2024)

Figure 62. Abbott Revenue Growth Rate in Healthcare-Acquired Infection Business (2019-2024)

Figure 63. BD Revenue Growth Rate in Healthcare-Acquired Infection Business (2019-2024)

Figure 64. Hologic Revenue Growth Rate in Healthcare-Acquired Infection Business (2019-2024)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Hospital Acquired Infection Testing Market Research Report 2025

Hospital Acquired Urinary Tract Infection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hospital acquired Urinary Tract Infection Testing Market Insights Forecast to 2030

Infection Prevention Market

Acute Wound Care Market

Global Staphylococcal Infection Treatment Market Insights Forecast to 2030

Global Pseudomonas Aeruginosa Infection Treatment Market Insights Forecast to 2030

Global Infection Surveillance Solutions Market Research Report 2024

Global Infection Control Devices Market Insights Forecast to 2030

Global Infection Prevention Products Market Insights Forecast to 2030

Global Healthcare Distribution Market Insights Forecast to 2030

Global Nosocomial Infection Treatment Market Insights Forecast to 2030

Hospital Acquired Infections Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Hospital Acquired Infections Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Hospital Acquired Infection HAI Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Household Healthcare Market Insights Forecast to 2030

Global Acute Hospital Care Market Insights Forecast to 2030

Health and Medical Insurance Market

Healthcare associated Infectious Disease Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

120 Pages

Type: Report

Code: QYRE-Auto-21N6899

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Pediatric Vaccines Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-13M6952

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Poliomyelitis Vaccines Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29X7355

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Varicella Virus (Chickenpox) Vaccine Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28B293

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Healthcare-Acquired Infection Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-24Z5686

Global Healthcare-Acquired Infection Market Insights, Forecast to 2030

FEATURED COMPANIES

Healthcare-Acquired Infection Market Size

Healthcare-Acquired Infection Market

Scope of Healthcare-Acquired Infection Market Report

Chapter Outline

FAQ for this report

How fast is Healthcare-Acquired Infection Market growing?

What is the Healthcare-Acquired Infection Market size in 2030?

Who are the main players in the Healthcare-Acquired Infection Market report?

What are the Application segmentation covered in the Healthcare-Acquired Infection Market report?

What are the Type segmentation covered in the Healthcare-Acquired Infection Market report?

Recommended Reports

Hospital Infrastructure

Medical Devices & Equipment

Critical Care & ICU

FEATURED COMPANIES

RELATED REPORTS